These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24877031)

  • 1. LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis.
    Hara M; Kirita A; Kondo W; Matsuura T; Nagatsuma K; Dohmae N; Ogawa S; Imajoh-Ohmi S; Friedman SL; Rifkin DB; Kojima S
    Springerplus; 2014; 3():221. PubMed ID: 24877031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L(59) TGF-β LAP degradation products serve as a promising blood biomarker for liver fibrogenesis in mice.
    Hara M; Inoue I; Yamazaki Y; Kirita A; Matsuura T; Friedman SL; Rifkin DB; Kojima S
    Fibrogenesis Tissue Repair; 2015; 8():17. PubMed ID: 26379781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease.
    Yokoyama H; Masaki T; Inoue I; Nakamura M; Mezaki Y; Saeki C; Oikawa T; Saruta M; Takahashi H; Ikegami M; Hano H; Ikejima K; Kojima S; Matsuura T
    Heliyon; 2019 Feb; 5(2):e01231. PubMed ID: 30815603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of acute liver injury by suppressing plasma kallikrein-dependent activation of latent TGF-β.
    Li M; Qin XY; Furutani Y; Inoue I; Sekihara S; Kagechika H; Kojima S
    Biochem Biophys Res Commun; 2018 Oct; 504(4):857-864. PubMed ID: 30219233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis.
    Pedersen RS; Nissen NI; Jensen C; Thorlacius-Ussing J; Manon-Jensen T; Olesen ML; Langholm LL; Diab HMH; Jorgensen LN; Hansen CP; Chen IM; Johansen JS; Karsdal MA; Willumsen N
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latency-associated Peptide Degradation Fragments Produced in Stellate Cells and Phagocytosed by Macrophages in Bile Duct-ligated Mouse Liver.
    Inoue I; Qin XY; Masaki T; Mezaki Y; Matsuura T; Kojima S; Furutani Y
    J Histochem Cytochem; 2021 Nov; 69(11):723-730. PubMed ID: 34674567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neovessel formation promotes liver fibrosis via providing latent transforming growth factor-β.
    Sakata K; Eda S; Lee ES; Hara M; Imoto M; Kojima S
    Biochem Biophys Res Commun; 2014 Jan; 443(3):950-6. PubMed ID: 24361885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta.
    Okuno M; Akita K; Moriwaki H; Kawada N; Ikeda K; Kaneda K; Suzuki Y; Kojima S
    Gastroenterology; 2001 Jun; 120(7):1784-800. PubMed ID: 11375959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells.
    Roth-Eichhorn S; Kühl K; Gressner AM
    Hepatology; 1998 Dec; 28(6):1588-96. PubMed ID: 9828223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired liver regeneration in mice by lipopolysaccharide via TNF-alpha/kallikrein-mediated activation of latent TGF-beta.
    Akita K; Okuno M; Enya M; Imai S; Moriwaki H; Kawada N; Suzuki Y; Kojima S
    Gastroenterology; 2002 Jul; 123(1):352-64. PubMed ID: 12105863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor β latency: A mechanism of cytokine storage and signalling regulation in liver homeostasis and disease.
    Li Y; Fan W; Link F; Wang S; Dooley S
    JHEP Rep; 2022 Feb; 4(2):100397. PubMed ID: 35059619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondin type 1 motif, 1 as a central activator of transforming growth factor beta.
    Bourd-Boittin K; Bonnier D; Leyme A; Mari B; Tuffery P; Samson M; Ezan F; Baffet G; Theret N
    Hepatology; 2011 Dec; 54(6):2173-84. PubMed ID: 21826695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta.
    Ribeiro SM; Poczatek M; Schultz-Cherry S; Villain M; Murphy-Ullrich JE
    J Biol Chem; 1999 May; 274(19):13586-93. PubMed ID: 10224129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells.
    Roth S; Michel K; Gressner AM
    Hepatology; 1998 Apr; 27(4):1003-12. PubMed ID: 9537440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented binding and activation of latent transforming growth factor-beta by a tryptic fragment of latency associated peptide.
    Abe M; Oda N; Sato Y; Shibata K; Yamasaki M
    Endothelium; 2002; 9(1):25-36. PubMed ID: 12901358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.